Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00275249 · ClinicalTrials.gov registry record · NA
Evolution of Analgesic Tolerance With Opioids
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00275249 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 60 participants.
The verdict
NCT00275249, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the extent to which analgesic tolerance develops in chronic pain patients who are either started on opioids or who receive an increase in pre-study opioid dose level and then observed during long-term (20 weeks) stable opioid therapy. In addition to clinical measures of relief of ongoing chronic pain, estimation of tolerance development will be supplemented by periodic assessment of the anti-nociceptive effects of opioids using the brief thermal sensitization model.
Interventions
- DRUG levorphanol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2001-03 |
| Est. Completion | 2005-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00275249
The ClinicalTrials.gov registry entry for NCT00275249 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which levorphanol is the first listed.
NCT00275249 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00275249 about?
NCT00275249 is a clinical study titled "Evolution of Analgesic Tolerance With Opioids". The purpose of this study is to determine the extent to which analgesic tolerance develops in chronic pain patients who are either started on opioids or who receive an increase in pre-study opioid dose level and then observed during long-term (20 weeks) stable opioid therapy. In addition to clinical...
What is the current status of trial NCT00275249?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2001-03. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00275249?
The interventions under investigation include: levorphanol (DRUG).
Who is sponsoring clinical trial NCT00275249?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.